BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25458539)

  • 1. Engineering TGF-β superfamily ligands for clinical applications.
    Kwiatkowski W; Gray PC; Choe S
    Trends Pharmacol Sci; 2014 Dec; 35(12):648-57. PubMed ID: 25458539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
    Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP
    Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the BMP-2-BRIA ectodomain complex.
    Kirsch T; Sebald W; Dreyer MK
    Nat Struct Biol; 2000 Jun; 7(6):492-6. PubMed ID: 10881198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promiscuity and specificity in BMP receptor activation.
    Mueller TD; Nickel J
    FEBS Lett; 2012 Jul; 586(14):1846-59. PubMed ID: 22710174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A silent H-bond can be mutationally activated for high-affinity interaction of BMP-2 and activin type IIB receptor.
    Weber D; Kotzsch A; Nickel J; Harth S; Seher A; Mueller U; Sebald W; Mueller TD
    BMC Struct Biol; 2007 Feb; 7():6. PubMed ID: 17295905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergence and convergence of TGF-beta/BMP signaling.
    Miyazono K; Kusanagi K; Inoue H
    J Cell Physiol; 2001 Jun; 187(3):265-76. PubMed ID: 11319750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence.
    Hariharan R; Pillai MR
    Proteins; 2008 Jun; 71(4):1853-62. PubMed ID: 18175316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
    Keah HH; Hearn MT
    J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production, Isolation, and Structural Analysis of Ligands and Receptors of the TGF-β Superfamily.
    Huang T; Hinck AP
    Methods Mol Biol; 2016; 1344():63-92. PubMed ID: 26520118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A road map toward defining the role of Smad signaling in hematopoietic stem cells.
    Utsugisawa T; Moody JL; Aspling M; Nilsson E; Carlsson L; Karlsson S
    Stem Cells; 2006 Apr; 24(4):1128-36. PubMed ID: 16357343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.
    Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS
    Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Engineering of the TGF-β Signaling Pathway.
    Zi Z
    J Mol Biol; 2019 Jul; 431(15):2644-2654. PubMed ID: 31121181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functionally diverse heteromeric traps for ligands of the transforming growth factor-β superfamily.
    Kumar R; Grinberg AV; Li H; Kuo TH; Sako D; Krishnan L; Liharska K; Li J; Grenha R; Maguire MC; Briscoe SD; Pearsall RS; Herrin BR; Suragani RNVS; Castonguay R
    Sci Rep; 2021 Sep; 11(1):18341. PubMed ID: 34526551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII.
    de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC
    Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
    J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta-related proteins: an ancestral and widespread superfamily of cytokines in metazoans.
    Herpin A; Lelong C; Favrel P
    Dev Comp Immunol; 2004 May; 28(5):461-85. PubMed ID: 15062644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric interactions of TGF-β and BMP receptors.
    Ehrlich M; Gutman O; Knaus P; Henis YI
    FEBS Lett; 2012 Jul; 586(14):1885-96. PubMed ID: 22293501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing.
    Cho TJ; Gerstenfeld LC; Einhorn TA
    J Bone Miner Res; 2002 Mar; 17(3):513-20. PubMed ID: 11874242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a 60-kDa cell surface-associated transforming growth factor-beta binding protein that can interfere with transforming growth factor-beta receptor binding.
    Piek E; Franzén P; Heldin CH; ten Dijke P
    J Cell Physiol; 1997 Dec; 173(3):447-59. PubMed ID: 9369958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on transforming growth factor-β (TGF-β): sources, types, functions and clinical applicability for cartilage/bone healing.
    Patil AS; Sable RB; Kothari RM
    J Cell Physiol; 2011 Dec; 226(12):3094-103. PubMed ID: 21344394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.